Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OSU6162 as add-on in SSRI/SNRI-resistant Depression (ODEN)
NCT05641623Phase 2Recruiting
- Sponsor
- University of Gothenburg
- Start
- Apr 2022
- Primary completion
- May 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of OSU-6162 in treatment-resistant depression (TRD), sponsored by University of Gothenburg. Started Apr 2022; status: recruiting.
02
Drugs
OSU-6162
03
Conditions
treatment-resistant depression (TRD)
Beyond the preview
Go deeper on NCT05641623.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05641623.